Showing results (151-160 of 586) with videos related to
Sort By:
Pageof 59
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.Diagnostic Microbiology and Infectious Disease|August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingR N Jones, K E Aldridge, A L Barry, et al.Journal of Clinical Microbiology|March 1, 1993
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized testsA L Barry, P C Fuchs, J H Jorgensen, et al.Journal of Clinical Microbiology|July 1, 1986
Selection of a reference lot of Mueller-Hinton agarH M Pollock, A L Barry, T L Gavan, et al.Antimicrobial Agents and Chemotherapy|November 1, 1982
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testingL W Ayers, R N Jones, A L Barry, et al.The Journal of Antimicrobial Chemotherapy|September 1, 1985
Cefpiramide: comparative in-vitro activity and beta-lactamase stabilityA L Barry, R N Jones, C Thornsberry, et al.Journal of Clinical Microbiology|September 1, 1993
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parametersA L Barry, P C Fuchs, S D Allen, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamineA L Barry, M A Pfaller, P C Fuchs, et al.Journal of Clinical Microbiology|January 1, 1989
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteriaR J Zabransky, D G Bobey, A L Barry, et al.Journal of Clinical Microbiology|September 1, 1984
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratoriesR N Jones, C Thornsberry, A L Barry, et al.Pageof 59